PLA2G2A Gene - Phospholipase A2 Group IIA

Comprehensive genomic and functional analysis of PLA2G2A, a secreted phospholipase involved in inflammation, host defense, and cancer.

Gene Information Card

Symbol PLA2G2A
Full Name Phospholipase A2 Group IIA
Gene Type protein-coding
Chromosomal Location 1p36.13
NCBI Gene ID 5320 ncbi.nlm.nih.gov/gene/5320
Ensembl ID ENSG00000188257
UniProt ID P14555
OMIM ID 172411
HGNC ID 9031
Aliases PLA2B, PLA2L, PLA2S, sPLA2-IIA, MOM1

Description

PLA2G2A encodes a secreted phospholipase A2 (sPLA2) that catalyzes the hydrolysis of membrane phospholipids to release arachidonic acid and lysophospholipids, precursors of eicosanoids and platelet-activating factor. It plays a key role in inflammation, host defense against bacteria, and modulation of tumor progression. The gene is located on chromosome 1p36.13 and is expressed in various tissues including the intestine, prostate, and immune cells.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Colorectal Cancer PLA2G2A expression is associated with tumor suppression; loss of expression correlates with poor prognosis. PMID: 10655551, COSMIC
Inflammatory Bowel Disease Increased sPLA2-IIA activity contributes to mucosal inflammation and tissue damage. PMID: 11509682
Atherosclerosis Elevated PLA2G2A levels promote LDL oxidation and vascular inflammation. PMID: 15668377
Rheumatoid Arthritis Secreted PLA2G2A is found in synovial fluid and amplifies joint inflammation. PMID: 10720189
Sepsis PLA2G2A acts as an acute-phase protein; high levels correlate with severity. PMID: 10931852

Expression Profile

Tissue Expression
Tissue nTPM level
Prostate 12.5 Medium
Small Intestine 8.3 Medium
Colon 6.1 Low
Stomach 4.7 Low
Lung 2.1 Low
Spleen 1.8 Low
Liver 0.5 Not detected
Cell Line Expression
Cell Line nTPM Notes
HT-29 (Colorectal) 15.2 High expression
PC-3 (Prostate) 9.8 Medium expression
A549 (Lung) 3.4 Low expression
HeLa (Cervical) 1.2 Low expression
K-562 (Leukemia) 0.3 Not detected
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.331G>A (p.Gly111Arg) Missense <0.01% Unknown functional impact; rare population variant
c.487C>T (p.Arg163Trp) Missense <0.01% Predicted damaging by SIFT; not validated in disease
c.1A>G (p.Met1?) Start loss <0.01% Likely loss of function; no clinical association reported
Mutation functional classification

Loss of Function (LOF)

Start-loss mutations (e.g., p.Met1?) are predicted to abolish protein translation, leading to complete loss of enzymatic activity.

Gain of Function (GOF)

No gain-of-function mutations have been reported in PLA2G2A.

Dominant Negative (DN)

No dominant-negative mutations have been described for PLA2G2A.

Pathways

Arachidonic acid metabolism (Reactome: R-HSA-2142753)
Phospholipid hydrolysis (Reactome: R-HSA-1483206)
Innate immune system (Reactome: R-HSA-168249)

Protein Summary

The PLA2G2A protein (sPLA2-IIA) is a 144-amino acid secreted phospholipase with a conserved calcium-binding domain and catalytic histidine-aspartate dyad. It is synthesized as a preproenzyme and processed to the active form. The enzyme preferentially hydrolyzes phosphatidylethanolamine and phosphatidylglycerol, releasing arachidonic acid. It exhibits potent bactericidal activity against Gram-positive bacteria by disrupting their cell membrane. In cancer, sPLA2-IIA can act as a tumor suppressor in colorectal cancer but may promote inflammation in other contexts.

Related Products

Product name Cat.No. Species Gene ID
PLA2G2A Knockout HEK293 Cell Line EDJ-KQ1265 Human 5320 Details Get a Quote
PLA2G2A Knockout HeLa Cell Line EDJ-KQ54150 Human 5320 Details Get a Quote
PLA2G2A Knockout A-549 Cell Line EDJ-KQ62643 Human 5320 Details Get a Quote
PLA2G2A Knockout HCT 116 Cell Line EDJ-KQ71111 Human 5320 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: